Molecular assays for cell and gene therapy safety testing

Accelerate delivery with confident VCN and RCL analysis

mRNA strand on a green background
mRNA strand on a green background
Logo

Molecular assays for cell and gene therapy safety testing

Reliable and rapid molecular safety testing is essential to advancing cell and gene therapies (CGTs). Our quantitative polymerase chain reaction (qPCR) and digital polymerase chain reaction (dPCR) assays for vector copy number (VCN) and replication-competent lentivirus (RCL) provide the sensitivity, specificity, and reproducibility necessary for confident decision-making throughout your CGT workflow.

Designed for in-process control (IPC), drug product release testing (RT), and effective drug monitoring and patient follow-up, these molecular assays provide the analytical rigor needed to meet regulatory expectations, protect patients, and accelerate your path to clinical and commercial manufacturing.

Find your fit: a quick product guide

ApplicationPCR methodProduct
VCN assayqPCRMACS® qPCR COPYcheck Kit
dPCRMACS® dPCR COPYcheck Kit, human
RCL assayqPCRMACS® qPCR LENTIcheck Kit (VSV-G), human
dPCRMACS® dPCR LENTIcheck Kit (VSV-G), human
qPCRMACS® qPCR LENTIcheck Kit (BaEV), human
dPCRMACS® dPCR LENTIcheck Kit (BaEV), human

To ensure full coverage of lentiviral vectors used in manufacturing, RCL detection is available for both VSV-G (vesicular stomatitis virus glycoprotein) and BaEV (baboon envelope glycoprotein) gene sequences.

Accelerate your CGT safety testing with advanced molecular solutions

Icon depicting trusted performance

Trusted performance

Designed and optimized for manufacturing control, our protocols and assays provide you with the accuracy and consistency you need to advance CGT programs with confidence.

Icon depicting simple assay integration

Simple assay integration

Seamlessly integrate our assays into your workflow using detailed protocols for multiple platforms, streamlining operations and increasing efficiency.

Icon depicting faster validation

Faster validation

Significantly shorten your validation timelines with expert training, ready-to-use analytical method validation plans, and tailored on-site guidance.

Choose between qPCR and dPCR assays for VCN and RCL

Quantitative PCR (qPCR) and digital PCR (dPCR) are essential analytical tools for CGT workflows. Both methods enable precise quantification of VCN and highly sensitive detection of RCL. While qPCR remains the industry standard for rapid, high-throughput testing, dPCR offers absolute quantification without standard curves and superior precision, particularly for low copy numbers.

Depending on your individual requirements, these technologies support robust, compliant, and scalable analytics throughout CGT development and manufacturing. Whether you need qPCR- or dPCR-based VCN and RCL assays, our COPYcheck and LENTIcheck solutions can support your CGT process. If you are unsure which assay is the best fit, connect with our experts or review the overview below.

Comparison qPCR and dPCR

qPCR strengthsdPCR strengths
Well-established technology with extensive protocol availabilityEmerging technology with strong fit for high sensitivity assays
Broad dynamic range for variable sample concentrationsDigital quantification allows for very high reproducibility
Fast, cost-effective instrumentationOutstanding sensitivity for low copy number detection
High throughput with automation optionsAbsolute quantification without standard curves

Not sure which assay fits your vector system?

All products for molecular assays

These products are intended for use with lentiviral vectors provided by Miltenyi Bioindustry – a division of Miltenyi Biotec. For compatibility with additional vector systems, please get in touch with Miltenyi Biotec Technical Support.

6 products found

|

You have previously chosen International as your location.
What do you want to do?